Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia
Clinical Chemistry · 01.03.2023 · 69 (3) · 239-250
DOI: 10.1093/clinchem/hvac200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 23.01.2023. Verfasst von Qiaowei Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Hunan Jiahui Genetics Hospital, Changsha, Hunan, China. Hauptthemen laut MEDLINE: beta-Thalassemia, alpha-Thalassemia. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Science and Technology Innovation Program of Hunan Province.
Abstract (Originalsprache)
Background
The aim is to evaluate the clinical utility of a long-read sequencing-based approach termed comprehensive analysis of thalassemia alleles (CATSA) in prenatal diagnosis of thalassemia.
Methods
A total of 278 fetuses from at-risk pregnancies identified in thalassemia carrier screening by PCR-based methods were recruited from 9 hospitals, and PCR-based methods were employed for prenatal diagnosis. CATSA was performed retrospectively and blindly for all 278 fetuses.
Results
Among the 278 fetuses, 263 (94.6%) had concordant results and 15 (5.4%) had discordant results between the 2 methods. Of the 15 fetuses, 4 had discordant thalassemia variants within the PCR detection range and 11 had additional variants identified by CATSA. Independent PCR and Sanger sequencing confirmed the CATSA results. In total, CATSA and PCR-based methods correctly detected 206 and 191 fetuses with variants, respectively. Thus, CATSA yielded a 7.9% (15 of 191) increment as compared with PCR-based methods. CATSA also corrected the predicted phenotype in 8 fetuses. Specifically, a PCR-based method showed one fetus had homozygous HBB c.52A > T variants, while CATSA determined the variant was heterozygous, which corrected the predicted phenotype from β-thalassemia major to trait, potentially impacting the pregnancy outcome. CATSA additionally identified α-globin triplicates in 2 fetuses with the heterozygous HBB c.316-197C > T variant, which corrected the predicted phenotype from β-thalassemia trait to intermedia and changed the disease prognosis.
Conclusions
CATSA represents a more comprehensive and accurate approach that potentially enables more informed genetic counseling and improved clinical outcomes compared to PCR-based methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Hunan Jiahui Genetics Hospital, Changsha, Hunan, China.
- Changsha Hospital for Maternal and Child Health Care, Changsha, Hunan, China.
- Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Women and Children's Hospital, School of Medicine and School of Public Health, Xiamen University, Xiamen, China.
- Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China.
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
Förderung
- National Key Research and Development Program of China
- Science and Technology Innovation Program of Hunan Province
Zitieren
APA
Liang, Q., He, J., Li, Q., Zhou, Y., Liu, Y., Li, Y., Tang, L., Huang, S., Li, R., Zeng, F., Mao, A., Liu, Y., Liang, D., & Wu, L. (2023). Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia. Clinical Chemistry, 69(3), 239-250. https://doi.org/10.1093/clinchem/hvac200
Vancouver
Liang Q, He J, Li Q, Zhou Y, Liu Y, Li Y, et al. Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia. Clinical Chemistry. 2023;69(3):239-250. doi:10.1093/clinchem/hvac200
BibTeX
@article{Liang2023,
author = {Liang, Qiaowei and He, Jun and Li, Qing and Zhou, Yulin and Liu, Yanqiu and Li, Youqiong and Tang, Lingfang and Huang, Shengwen and Li, Rong and Zeng, Fanqian and Mao, Aiping and Liu, Yinyin and Liang, Desheng and Wu, Lingqian},
title = {Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia},
journal = {Clinical Chemistry},
year = {2023},
volume = {69},
number = {3},
pages = {239--250},
doi = {10.1093/clinchem/hvac200}
}
EUVIMED